Magnetic resonance imaging of functional Schwann cell transplants labelled with magnetic microspheres
Introduction
Cell therapies for CNS disorders have an extensive experimental pedigree and in some cases are poised to make the translational step to phase 1 clinical trials. These include the use of glial cell transplants to mediate or promote regenerative processes following traumatic spinal cord injury (SCI) or in demyelinating diseases such as multiple sclerosis (MS). In experimental models, transplantation of both Schwann cells (SCs) and olfactory ensheathing cells (OECs) promotes axon regeneration following SCI (Li et al., 1997, Li et al., 2003, Ramón-Cueto et al., 1998, Xu et al., 1999, Ramon-Cueto et al., 2000, Lu et al., 2002, Nash et al., 2002, Keyvan-Fouladi et al., 2003, Fouad et al., 2005) and leads to remyelination of focal areas of CNS demyelination (Duncan et al., 1981, Franklin et al., 1996, Imaizumi et al., 1998, Barnett et al., 2000, Kohama et al., 2001, Brierley et al., 2001, Sasaki et al., 2004, Bachelin et al., 2005). An important technical development to have emerged in recent years is the use of imaging methods to follow the in vivo fate of transplanted cells. These techniques, although still in laboratory development, have significant potential value for the translation of cell therapeutic approaches to clinical disease, enabling the efficacy of the transplant procedure to be related to clinical outcome.
There are several imaging modalities that can be used to track the fate of labelled cells in vivo. Optical methods, such as fluorescence and bioluminescence, have been widely used in laboratory-based studies for cell tracking (Massoud and Gambhir, 2003). However, the limited tissue penetration of the emitted light and the requirement, in the case of bioluminescence, to transfect the cells with luciferase limit translation of this technology to the clinic. Magnetic resonance imaging (MRI) and nuclear imaging (positron emission tomography (PET) and single-photon emission computed tomography (SPECT)) are in routine clinical use and have been used for cell tracking purposes in preclinical studies in vivo (Massoud and Gambhir, 2003, Herschman, 2003, Bulte and Kraitchman, 2004). However, the nuclear imaging methods have limited spatial resolution, may also require genetic modification of the cells and use radiochemicals that may be toxic and whose short half-life allows imaging of the cells for only relatively short periods of time (24–48 h). MRI, on the other hand, has relatively good spatial resolution and employs stable and comparatively non-toxic cell labels that allow cell tracking over much longer periods (Bulte and Kraitchman, 2004). The most widely used cell labels for MRI are based on nanometer-sized ultrasmall superparamagnetic-iron oxide (USPIO) particles. Recently, a commercially available ‘magnetic microsphere’ preparation has been developed that has significant advantages over USPIO as an MRI-detectable cell label. These micron-sized beads produce a much greater distortion of the magnetic field than the considerably smaller USPIO and are therefore easier to detect. In cultured cells, single particles could be detected, while in mouse embryos that had been injected at the single cell stage particles could be detected in daughter cells at embryonic day 11.5 (Shapiro et al., 2004). Recently, single primary mouse hepatocytes, labelled with micron-sized beads, were detected in vivo following their transplantation into the spleens of recipient mice (Shapiro et al., 2005a). In the case of USPIO, cell detection requires labelling with multiple particles, and detection can be lost if subsequent cell division results in label dilution. However, because of the greater sensitivity of micron-sized particles, it should be possible to follow the cells over many more divisions, even though there are fewer particles per cell (Hinds et al., 2003, Shapiro et al., 2004). In tissue culture studies, the growth and differentiation of haematopoietic CD34+ve and mesenchymal stem cells were shown to be unaffected by internalisation of these magnetic microspheres (Hinds et al., 2003), while the injection and subsequent cellular uptake of these particles appeared not to adversely affect mouse embryonic development (Shapiro et al., 2004). Thus far, however, the value of magnetic microspheres in glial cell transplantation has not been addressed and, in particular, whether the intracellular presence of these microspheres interferes with survival, differentiation and repair capabilities of the transplanted cells. Specifically, retention of glial cell function in vivo by magnetic microsphere-labelled primary cells has not been irrefutably demonstrated. We have shown previously that glial cells can be labelled in culture with USPIOs, that the labelled cells retain their differentiated function and that they can be detected in vivo and ex vivo following their transplantation into a demyelinated lesion in the spinal cord of the rat (Dunning et al., 2004). In this study, we demonstrate that glial cells may be labelled with 1.63 μm diameter magnetic microspheres and that labelled SCs transplanted into a rodent model of persistent demyelination in the spinal cord are visible in vivo and ex vivo using MRI for up to 4 weeks after transplantation. Moreover, the labelled SCs were able to differentiate into myelinating cells, thus clearly retaining their functional integrity, and were the main cell responsible for the observed signal reduction in vivo. This study therefore identifies a new MRI-detectable cell label for transplanted glial cells and represents a significant step towards the development of clinically applicable imaging protocols that can be used in the translation of experimental cell therapies into clinical practice.
Section snippets
Preparation of primary glial cell cultures
Primary SC cultures were generated using a protocol modified from that of Brockes et al. (1979). Briefly, both sciatic nerves were dissected from 2-day-old Fischer rat pups, dissociated into single cells by physical disruption and enzymatic digestion, resuspended in 10% Fetal Bovine Serum (FBS, Sigma) and plated onto poly-l-lysine (PLL, 13.3 μg/ml, Sigma)-coated 25 cm2 tissue culture flasks (Fischer Scientific, Loughborough, UK). The cultures were grown in Dulbecco's modified Eagle's Medium
Labelling of Schwann cells and other glial cells with magnetic microspheres in vitro
We first determined the optimal magnetic microsphere concentration to label primary SCs in vitro. SC cultures were incubated with increasing concentrations of magnetic microspheres (1.6 μm diameter, concentrations of 3, 15, 30 and 60 × 106 microspheres per ml) for 24 h, after which time the number of microspheres within the cytoplasm was assessed. Discrete inclusions were present within labelled cells, visualised using phase and fluorescent microscopy (Fig. 1A). The average number of
Discussion
Nanometer-sized ultrasmall dextran-coated iron oxide particles (USPIO) are being widely used to label cells for the purposes of cell tracking in vivo using non-invasive MRI techniques (Bulte and Kraitchman, 2004). Current evidence indicates that labelling can be achieved without significant loss of cell function (Lee et al., 2004, Dunning et al., 2004). Furthermore, current phase III trials with USPIOs, and materials which promote USPIO endocytosis (Frank et al., 2003, Arbab et al., 2004),
Acknowledgments
The authors would like to thank Mike Peacock for his assistance. This work was funded by the International Spinal Research Trust.
References (38)
- et al.
Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI
Blood
(2004) - et al.
Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve
Brain Res.
(1979) - et al.
Detection of single mammalian cells by high-resolution magnetic resonance imaging
Biophys. J.
(1999) - et al.
Transplantation of rat Schwann cells grown in tissue culture into the mouse spinal cord
J. Neurol. Sci.
(1981) - et al.
Nuclear magnetic resonance (NMR) imaging of iron oxide-labeled neural transplants
Exp. Neurol.
(1993) Micro-PET imaging and small animal models of disease
Curr. Opin. Immunol.
(2003)- et al.
Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells
Blood
(2003) - et al.
In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord
Exp. Neurol.
(2004) - et al.
Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia
Neuron
(2000) - et al.
Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates
Curr. Pharm. Biotechnol.
(2004)
Efficient myelin repair in the macaque spinal cord by autologous grafts of Schwann cells
Brain
Identification of a human olfactory ensheathing cell that can effect transplant-mediated remyelination of demyelinated CNS axons
Brain
Remyelination of demyelinated CNS axons by transplanted human Schwann cells: the deleterious effects of contaminating fibroblasts
Cell Transplant.
Monitoring cell therapy using iron oxide MR contrast agents
Curr. Pharm. Biotechnol.
Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination
Proc. Natl. Acad. Sci. U. S. A.
Superparamagnetic iron oxide (SPIO)-labelled Schwann cells and olfactory ensheathing cells can be traced in vivo by magnetic resonance imaging and retain functional properties following transplantation into the CNS
J. Neurosci.
Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord
J. Neurosci.
Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents
Radiology
Schwann cell-like myelination following transplantation of an olfactory bulb-ensheathing cell line into areas of demyelination in the adult CNS
Glia
Cited by (32)
Cell Surveillance Using Magnetic Resonance Imaging
2021, Molecular Imaging: Principles and PracticeNeuroglia as targets for drug delivery systems: A review
2017, Nanomedicine: Nanotechnology, Biology, and MedicineCitation Excerpt :In addition, recent findings reveal that Schwann cells play an important role in the onset and development of peripheral nerve inflammatory diseases, polyneuropathies, and neuropathic pain conditions, thus making them promising targets for drug delivery systems. Very few studies have evaluated the effect of nanoparticles in Schwann cells, with just two reports determining the use of superparamagnetic iron oxide nanoparticles in Schwann cells for use as markers to track their migration in vivo, using MRI.150,151 In another separate study, iron oxide nanoparticles conjugated to three neurotrophic factors – β nerve growth factor (β NGF), glial-cell derived factor (GDNF) and basic fibroblast growth factor (FGF-2) – were used to test the feasibility of embedding them into a neural scaffold to promote peripheral nerve regeneration.152
Iron oxide nanomaterials for functional imaging
2016, Nanobiomaterials in Medical Imaging: Applications of NanobiomaterialsIn vivo nanoneurotoxicity screening using oxidative stress and neuroinflammation paradigms
2013, Nanomedicine: Nanotechnology, Biology, and MedicineTransplantation of magnetically labeled mesenchymal stem cells in a model of perinatal brain injury
2010, Stem Cell ResearchCitation Excerpt :Our present study added to these findings by directly injecting stem cells to the lesion site, using a well-characterized model for PVWMI and a behavioral test specific for corticospinal function, and a method for tracking transplanted cells in vivo. Identifying the location of transplanted cells, both in vivo and postmortem, aids the understanding of both the fate of the stem cells posttransplantation and their possible mechanisms of therapeutic actions (Dunning et al., 2004, 2006). A drawback is the potential toxic effect of the label on the stem cells and even the host tissue.
Magnetic resonance imaging of cells in experimental disease models
2009, Progress in Nuclear Magnetic Resonance Spectroscopy